Committed to staying ahead with pioneering glass packaging solutions that answer the changing needs of the pharmaceutical industry, SGD Pharma is set to showcase its latest innovations at CPhI Frankfurt 2022

Paris La Défense, FRANCE – 18th October 2022: Global market leader in glass primary packaging solutions, SGD Pharma, will present its pioneering new products and services on its booth 30D40 at CPhI Frankfurt held 1-3rd November 2022 in Frankfurt, Germany.

The company will debut IDENCY, the next generation of Type I glass multi-dose vials that combine “easy to operate” features on existing filling lines on top of superior strength, mechanical resistance and chemical durability. Developed as the solution for pharmaceutical companies facing increased supply chain pressures from the growing demand for parenteral drugs, the IDENCY technological innovation has been designed by SGD Pharma to complement existing portfolios and is suitable for all parenteral drugs, especially the most sensitive ones. IDENCY is a solution of choice in cases of delamination risks, drug or buffer compatibility challenges, breakage or any supply chain shortage in converting vials.

Also, to be introduced at CPhI is SGD Pharma Plus, the company’s new Global Services Center where customers can discover the wide array of options for additional features and finishes to enhance their pharma-grade vials.

These include;

• Ready-to-Use molded glass vials: which speed up time to market and reduce total cost of ownership as a result of increased quality and flexibility.
• Pre-treated glass for thermosealing applications: a ready-to-seal bottle treatment for an optimal hermetic seal, typical applications are antibiotics and VMS.
• Type I training tool: an educational platform that allows customers to benefit from SGD Pharma’s world-class expertise.
• Inside vials siliconization: which maximises product value while providing additional protection.
• Plastic coating and printing: helping to make your product stand out on shelves with unique customization options.

SGD Pharma will also present the extension of its unique Clareo range of high-quality Type II premium glass vials for injectable drugs with 6 and 10ml vials. As part of continuous improvement efforts to enhance glass performance and ensure patient safety, SGD Pharma developed Clareo premium glass vials with an ideal combination of increased uniform wall thickness and higher cosmetic quality.

EasyLyo, SGD Pharma’s vials more suited to extreme conditions encountered during the lyophilization process available in sizes 5, 20, 25, 30, 50 and 100ml, to be displayed.

Ensiemo, a child-resistant packaging solution ideally suited for essential oils and cannabidiols using pharmaceutical grade glass and accurate dropper dosage, will also be displayed at CPhI to extend the ranges of products available for pharma, biotech, veterinary and CDMO organizations.

SGD Pharma will also show its leading Sterinity Type I molded glass Ready-to-Use vials which are mechanically resistant with high-quality sterilization and product validation processes. Designed to meet the rigorous requirements of the pharmaceutical industry and suitable for multi-dose and intravenous drugs, Sterinity vials will be shown in a range of sizes and glass colourways: including 20, 25, 50 and 100ml, in both clear and amber glass. The ideal solution for small batches of specialty drugs.

Olivier Rousseau, CEO, SGD Pharma, explains “CPhI is an important event among the pharma community, and we look forward to sharing our high-quality, innovative packaging solutions with our partners. The industry has faced significant challenges during 2020, 2021 and now 2022 with the ongoing impact of war and energy price and supply chain pressures. This means that it is more important than ever to innovate and meet our customers’ needs with new products and solutions that enable them to bring their drugs to product quickly and safely.”

Join us at our booth 30D40 to meet the team and find out more about our new innovations.

Marketing & Communication SGD Pharma   

Jean-Pascal Marquié – jean-pascal.marquie@sgdgroup.com       

The Scott Partnership   

Hannah Steele– hls@scottpr.com / sgdpharma@scottpr.com